Form 4: Hims & Hers CLO Earns Performance-Based Stock Award

Hims & Hers Health, Inc.'s Chief Legal Officer, Soleil Boughton, earned 273,794 shares of Class A common stock through performance-based restricted stock units.

Summary

• Soleil Boughton, Chief Legal Officer of Hims & Hers Health, Inc., acquired 273,794 shares of Class A Common Stock.
• The acquisition was due to the earning of performance-based restricted stock units (PRSUs) at a price of $0 per share.
• The Compensation Committee of the Company's Board of Directors certified that the performance criteria for this award were met as of February 23, 2026.
• Following this transaction, Soleil Boughton beneficially owns 445,623 shares of Class A Common Stock.
• The shares underlying the PRSUs are scheduled to be delivered to the Reporting Person on or about March 15, 2026.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive event, reflecting the successful achievement of performance targets by the Chief Legal Officer, which is a good sign for internal goal attainment and executive retention.

Positives

• The Chief Legal Officer earned a significant number of shares (273,794) through performance-based awards, indicating that pre-established company performance criteria were met.
• The earning of PRSUs aligns executive incentives with shareholder value creation.

Future Outlook

The shares underlying the performance-based restricted stock units are expected to be delivered to the Chief Legal Officer on or about March 15, 2026.

Management Comments

• The performance criteria established in connection with this award has been met as of February 23, 2026, as certified by the Compensation Committee of the Company's Board of Directors.

Industry Context

StockSavvy.ai notes that the use of performance-based restricted stock units is a standard practice in executive compensation across various industries, designed to incentivize long-term performance and align management interests with those of shareholders.

Stakeholder Impact

• Shareholders: The earning of performance-based awards by an executive can be viewed positively as it indicates the achievement of company goals, potentially benefiting long-term shareholder value.
• Employees: Reflects a compensation structure that rewards performance, which can be a positive signal for employee motivation and retention.

Next Steps

• Delivery of 273,794 shares of Class A common stock to Soleil Boughton on or about March 15, 2026.

Key Dates

Recommendation

This Form 4 filing details a routine insider transaction related to executive compensation through performance-based restricted stock units. It does not introduce new fundamental information that would warrant a change in investment recommendation, as the earning of these shares is an expected outcome of pre-established performance criteria being met.

Keywords

Hims & Hers Health, HIMS, Form 4, Insider Transaction, Executive Compensation, Restricted Stock Units, Performance-Based Award, Stock Award